Denki Kagaku Kogyo Kabushiki Kaisha: Pharmaceuticals and Healthcare Company Profile, SWOT & Financial Report by ICDResearch

VIEWS: 1 PAGES: 35

More Info
									Denki Kagaku Kogyo Kabushiki Kaisha

_________________________________________________________________________________



Denki Kagaku Kogyo Kabushiki                                                    Financial Snapshot

Kaisha                                                                          Operating Performance

Fast Facts                                                                      The company reported revenue of US$4,074.84
                                                                                million during the fiscal year 2011 (2011). The
                                        2-1-1, Nihonbashi Muromachi, Chuo-ku,   company's revenue grew at a CAGR of 9.88% during
Headquarters Address
                                        103-8338,Japan                          2007–2011, with an annual growth of 10.50% over
                                                                                2010. In 2011, the company recorded an operating
Telephone                               + 81 3 52905512
                                                                                margin of 6.57%, as against 6.56% in 2010.
Fax                                     + 81 3 52905059
                                                                                Revenue and Margins
Website                                 www.denka.co.jp

Ticker Symbol, Stock Exchange           4061, The Tokyo Stock Exchange

Number of Employees                     4,768

Fiscal Year End                         March

Revenue (in US$ million)                4,074.84

Revenue (in JPY million)                357,893.00




                                                                                Return on Equity
SWOT Analysis                                                                   The company recorded a return on equity (ROE) of
                                                                                8.48% for 2011, as compared to its peers, Idemitsu
Strengths                               Weaknesses                              Kosan Co., Ltd. (Ticker: 5019), Tosoh Corporation
                                                                                (Ticker: 4042) and Sumitomo Chemical Company,
Strengthening liquidity position        Anti-competitive litigation             Limited (Ticker: 4005), which recorded ROEs of
                                                                                11.80%, 6.07% and 4.68% respectively. The
                                        Overdependence on the Organic           company reported an operating margin of 6.57% in
Strengthening operational performance                                           2011.
                                        Materials division

Strengthening solvency position
                                                                                Return on Equity

Opportunities                           Threats

Increase in Automobile sales in the US Economic instability of the EU nations

                                        European regulations for chemicals
Infrastructure development in India
                                        production
Positive outlook for the global
                                        Labor shortage in Japan
pharmaceutical industry




                                                                                Liquidity Position

                                                                                The company reported a current ratio of 0.93 in 2011,
                                                                                as compared to its peers, Idemitsu Kosan Co., Ltd.,
                                                                                Tosoh Corporation and Sumitomo Chemical
                                                                                Company, Limited, which recorded current ratios of
                                                                                1.14, 1.12 and 1.38 respectively. As of March 2011,
                                                                                the company recorded cash and short-term
                                                                                investments of worth US$71.25 million, against
                                                                                US$101.95 million current debt. The company
                                                                                reported a debt to equity ratio of 0.69 in 2011 as
                                                                                compared to its peers, Idemitsu Kosan Co., Ltd.,
                                                                                Tosoh Corporation and Sumitomo Chemical
                                                                                Company, Limited, which recorded debt to equity
                                                                                ratios of 1.91, 2.21 and 1.99 respectively.




___________________________________________________________________________________________

Denki Kagaku Kogyo Kabushiki Kaisha - SWOT Profile                                                                     Page 1
Denki Kagaku Kogyo Kabushiki Kaisha

_________________________________________________________________________________


TABLE OF CONTENTS

1     Business Analysis ................................................................................................................................... 5
    1.1       Company Overview ................................................................................................................................................5
    1.2       Business Description ..............................................................................................................................................5
    1.3       Major Products and Services .................................................................................................................................6
2     Analysis of Key Performance Indicators ............................................................................................... 7
    2.1       Five Year Snapshot: Overview of Financial and Operational Performance Indicators ..........................................7
    2.2       Key Financial Performance Indicators .................................................................................................................10
      2.2.1       Revenue and Operating Profit .........................................................................................................................10
      2.2.2       Asset, Liabilities and Capex .............................................................................................................................11
      2.2.3       Net Debt vs. Gearing Ratio ..............................................................................................................................12
      2.2.4       Solvency ..........................................................................................................................................................13
      2.2.5       Valuation ............................................................................................................................
								
To top